Nutex Health (NASDAQ:NUTX) Price Target Raised to $333.00

Nutex Health (NASDAQ:NUTX) had its price target lifted by Lake Street Capital from $310.00 to $333.00 in a report issued on Monday,Benzinga reports. Lake Street Capital currently has a buy rating on the stock.

A number of other equities analysts have also weighed in on the stock. Zacks Research lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Ladenburg Thalmann & Co. Inc. assumed coverage on Nutex Health in a research report on Monday, October 26th. They issued a “buy” rating and a $336.00 price target for the company. Wall Street Zen downgraded Nutex Health from a “buy” rating to a “hold” rating in a research report on Saturday, October 31st. B. Riley Financial boosted their price target on shares of Nutex Health from $325.00 to $357.00 and gave the company a “buy” rating in a report on Monday. Finally, Weiss Ratings raised Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $342.00.

Nutex Health Price Performance

NUTX stock opened at $189.19 on Monday. Nutex Health has a 12 month low of $83.99 and a 12 month high of $226.16. The firm has a market capitalization of $1.30 billion, a P/E ratio of 7.95 and a beta of 0.66. The company has a current ratio of 4.76, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The firm has a 50 day moving average of $203.19 and a 200-day moving average of $151.91.

Nutex Health (NASDAQ:NUTX) last posted its earnings results on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.54 by $0.17. Nutex Health had a return on equity of 34.43% and a net margin of 20.68%. The company had revenue of $217.61 million for the quarter, compared to analysts’ expectations of $214.82 million. As a group, sell-side analysts predict that Nutex Health will post 27.70 earnings per share for the current fiscal year.

Insider Buying and Selling at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director owned 400 shares in the company, valued at $85,700. This represents a 33.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 44.68% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Large investors have recently modified their holdings of the stock. Private Advisor Group LLC acquired a new position in Nutex Health in the 3rd quarter valued at $1,184,000. Voya Investment Management LLC purchased a new position in Nutex Health during the third quarter worth about $206,000. HighTower Advisors LLC acquired a new stake in Nutex Health in the third quarter valued at about $1,104,000. Fulcrum Asset Management LLP lifted its position in Nutex Health by 168.8% in the third quarter. Fulcrum Asset Management LLP now owns 1,930 shares of the company’s stock valued at $405,000 after purchasing an additional 1,212 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its holdings in Nutex Health by 10.1% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,639 shares of the company’s stock valued at $773,000 after purchasing an additional 335 shares in the last quarter. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.